Julia M. Ford

A small molecule–kinase interaction map for clinical kinase inhibitors

Miles A. Fabian, William Biggs, Daniel K. Treiber et al. · Nature Biotechnology · 2005 · 1.9K citations · Full text

Molecular Docking, Drug Target, Clinical Kinase Inhibitors +4

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

Todd A. Carter, Lisa Wodicka, Neil P. Shah et al. · Proceedings of the National Academy of Sciences · 2005 · 554 citations · Full text

Activation State-Dependent Binding of Small Molecule Kinase Inhibitors: Structural Insights from Biochemistry

Lisa Wodicka, Pietro Ciceri, Mindy I. Davis et al. · Chemistry & Biology · 2010 · 122 citations

Drug Target, Signal Transduction, Biochemistry +12

Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease

Julia M. Ford, Carol Truman, Gordon Wilcock et al. · Clinical Pharmacology & Therapeutics · 1993 · 66 citations

Tumour necrosis factor-α gene polymorphisms and Alzheimer's disease

Doris Culpan, S.H. MacGowan, Julia M. Ford et al. · Neuroscience Letters · 2003 · 65 citations

Neurodegenerative Diseases, Alzheimer's Disease, Pathology +7